(Q34009817)

30 July 2017

1 reference

title

Polyanions--a lost chance in the fight against HIV and other virus diseases? (English)

1 reference

30 July 2017

M Lüscher-Mattli

1

1 reference

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

Antiviral Chemistry & Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

249-259

1 reference

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Synthesis of sulfated octadecyl ribo-oligosaccharides with potent anti-AIDS virus activity by ring-opening polymerization of a 1,4-anhydroribose derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

New acquisitions in the development of anti-HIV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Pharmacologic considerations for antiviral drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

The potential use of liposome-mediated antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Inhibition of entry of HIV into cells by poly(A).poly(U).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Polyanion inhibitors of human immunodeficiency virus and other viruses. 1. Polymerized anionic surfactants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Dextran sulfate is poorly absorbed after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Anti-HIV-1 activity of inorganic polyphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Drug targeting systems for antiviral agents: options and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Differential antiviral activity of derivatized dextrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Inhibition of influenza virus fusion by polyanionic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Sulfonic acid polymers are potent inhibitors of HIV-1 induced cytopathogenicity and the reverse transcriptases of both HIV-1 and HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

Sulfated polysaccharides extracted from sea algae as potential antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100401

10.1177/095632020001100401

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference